Klara Totpal Selected Research

Klara Totpal Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 03/2002
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2008 - 07/2004
2	Mesothelioma 01/2020 - 01/2019
2	Hereditary Neoplastic Syndromes (Cancer Syndrome, Hereditary) 01/2020 - 01/2019
2	Multiple Myeloma 01/2019 - 05/2009
2	Melanoma (Melanoma, Malignant) 01/2019 - 09/2007
2	Breast Neoplasms (Breast Cancer) 06/2010 - 09/2008
2	Lung Neoplasms (Lung Cancer) 12/2008 - 07/2004
2	Carcinoma (Carcinomatosis) 08/2006 - 03/2002
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Microsatellite Instability 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Weight Loss (Weight Reduction) 01/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Cytokine Release Syndrome 01/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Bites and Stings (Sting) 05/2015
1	Neuroblastoma 09/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2007
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2007

Drug/Important Bio-Agent (IBA)

8	LigandsIBA 01/2020 - 03/2002
7	AntibodiesIBA 01/2021 - 08/2006
6	Bispecific AntibodiesIBA 01/2021 - 05/2015
5	Death Domain ReceptorsIBA 09/2007 - 03/2002
3	CytokinesIBA 01/2020 - 11/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2005 - 03/2002
2	Deubiquitinating EnzymesIBA 01/2020 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2019
2	blinatumomabIBA 01/2017 - 05/2015
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2011 - 12/2008
2	Carboplatin (JM8)FDA LinkGeneric 12/2008 - 07/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2008 - 07/2004
2	Monoclonal AntibodiesIBA 12/2008 - 09/2008
1	Immune Checkpoint InhibitorsIBA 01/2022
1	AntigensIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Immunomodulating AgentsIBA 01/2020
1	Long-Acting Thyroid Stimulator (LATS)IBA 01/2020
1	UbiquitinIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	Lenalidomide (CC 5013)FDA Link 01/2019
1	Histones (Histone)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	Programmed Cell Death 1 ReceptorIBA 01/2017
1	Immunoglobulin FragmentsIBA 05/2015
1	MEHD7945AIBA 10/2011
1	drozitumabIBA 01/2011
1	FucoseIBA 06/2010
1	Trastuzumab (Herceptin)FDA Link 06/2010
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 05/2009
1	apomabIBA 12/2008
1	Antineoplastic Agents (Antineoplastics)IBA 09/2008
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 09/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 09/2008
1	Glucose (Dextrose)FDA LinkGeneric 09/2008
1	Insulin-Like PeptidesIBA 09/2008
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 09/2008
1	Docetaxel (Taxotere)FDA Link 09/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2008
1	Complement System Proteins (Complement)IBA 12/2007
1	Rituximab (Mabthera)FDA Link 12/2007
1	Messenger RNA (mRNA)IBA 09/2007
1	GlycosyltransferasesIBA 09/2007
1	Biomarkers (Surrogate Marker)IBA 09/2007
1	Peptides (Polypeptides)IBA 08/2006
1	Topoisomerase I InhibitorsIBA 05/2002
1	Proteins (Proteins, Gene)FDA Link 05/2002
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2002

Therapy/Procedure

11	Therapeutics 01/2022 - 03/2002
4	Immunotherapy 01/2021 - 10/2014
3	Drug Therapy (Chemotherapy) 12/2008 - 03/2002